Dapagliflozin Tablets 10 Mg – DAPILA 10

Dapagliflozin Tablets 10 Mg – A breakthrough in diabetes management and cardiovascular health.

DAPILA 10: The composition of Dapagliflozin 10mg contains an SGLT2 inhibitor indicated for the management of type 2 diabetes mellitus. By preventing glucose reabsorption in the renal tubules, it facilitates glucose elimination through urine. This not only helps lower blood sugar levels but also promotes weight loss and provides additional benefits in terms of cardiovascular and renal health. Dapagliflozin is typically used alongside diet and exercise to enhance glycemic control.

Recommended By Specialists:
Endocrinologists: It is mainly used to prefer t treat the disease associated with the management of Type 2 diabetes mellitus, especially in overweight or obese patients
General Physicians: It is used to prefer to treat the disease Type 2 diabetes, especially in patients who need weight loss and blood sugar control
Cardiologists: It should mainly be preferred for the treatment of patients with heart failure with reduced ejection fraction (HFrEF)

Key benefits of Dapagliflozin Tablets 10 Mg – DAPILA 10
SGLT2 Inhibition for Glycemic Control: Dapagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, promoting the excretion of excess glucose in the urine, leading to lower blood glucose levels.
Cardiovascular Protection: Clinical studies have shown that Dapagliflozin reduces the risk of hospitalization for heart failure and improves overall cardiovascular outcomes in patients with type 2 diabetes.
Renal Benefits: Dapagliflozin provides renal protection, slowing the progression of kidney disease in patients with type 2 diabetes and improving renal outcomes.

INDICATIONS:
Type 2 Diabetes Mellitus
Cardiovascular risk reduction in T2DM
Renal impairment management in diabetes